Physician

John Patrick Brady, M.D.

According to 2025 Medicare claims, John Brady, M.D. (NPI: 1356347546) practices nephrology in the Michigan City-La Porte, IN market, with the plurality of this provider's patient population coming from La Porte, IN. This provider's primary affiliated billing organization is DUNELAND NEPHROLOGY PC (NPI: 1598709685; TIN: 204993978) and primary practice location at 46304-9695. Brady is affiliated with the Main Street Rural Health Cedar ACO LLC (ACO ID: A5502), participating under the MSSP model.

Brady's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 521 traditional Medicare patients, billed 2,536 HCPCS/CPT codes, and received $315,639 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 964 prescription claims across 171 beneficiaries totaling $346,053 in drug costs, led by Xphozah (Tenapanor Hcl). DME data shows 135 claims. Open Payments data shows 10 records totaling $190. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a higher plateau to a lower plateau, from $216,123 to $346,053. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	767	3,820	$364,017
2016	726	3,252	$312,117
2017	715	3,179	$303,359
2018	724	3,184	$366,683
2019	666	3,100	$355,892
2020	657	3,137	$369,913
2021	664	3,564	$428,887
2022	594	3,271	$376,145
2023	554	2,658	$329,061
2024	521	2,536	$315,639

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	167	1,067	$216,123
2016	153	1,023	$391,688
2017	150	976	$460,939
2018	156	914	$185,782
2019	170	961	$189,220
2020	175	976	$171,561
2021	207	1,001	$180,894
2022	169	997	$200,048
2023	172	1,007	$201,881
2024	171	964	$346,053

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	116	$11,507
2016	N/R	77	$6,551
2017	N/R	80	$5,918
2018	N/R	74	$5,814
2019	N/R	120	$8,658
2020	N/R	108	$6,828
2021	N/R	96	$5,137
2022	N/R	100	$3,896
2023	N/R	96	$2,478
2024	N/R	135	$2,637

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	83	649	$262
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	113	249	$91
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	241	359	$83
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	186	629	$60
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	168	223	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xphozah	Tenapanor Hcl	23	1,320	$128,818
Velphoro	Sucroferric Oxyhydroxide	13	525	$47,860
Auryxia	Ferric Citrate	19	990	$44,983
Renvela	Sevelamer Carbonate	11	690	$33,368
Sevelamer Carbonate	Sevelamer Carbonate	82	5,324	$28,059

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	13	$796
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	44	$772
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	34	$414
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	21	$393
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	23	$263

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	10	$190	Otsuka America Pharmaceutical, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for John Patrick Brady, M.D.?

Tedicare shows public-source Medicare data for John Patrick Brady, M.D. (NPI 1356347546), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John Patrick Brady, M.D. have ACO affiliation data?

John Patrick Brady, M.D. is shown with ACO affiliation data for Main Street Rural Health Cedar ACO LLC (MSSP, ACO ID A5502).

What billing organization is linked to John Patrick Brady, M.D.?

John Patrick Brady, M.D. is linked to DUNELAND NEPHROLOGY PC (billing NPI 1598709685) in the available physician profile data.

Does John Patrick Brady, M.D. have Open Payments data?

John Patrick Brady, M.D. has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.